Omeicos Therapeutics, a biopharmaceutical spinout of research institute Max Delbrück Center for Molecular Medicine, achieved a first close of its series B round at €8.3m ($8.7m) on Wednesday.
The round was co-led by Vesalius Biocapital and plant construction company SMS Group.
German state-owned development bank KFW and public-private partnership High-Tech Gründerfonds (HTGF) and Ascension, a tech transfer office for a range of German universities, hospitals and institutes, also participated, as did VC Fonds Technologie Berlin, Falck Revocable Trust…
Omeicos is treated to $8.7m
Mar 3, 2017 •
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
University of Notre Dame tries new, supersized approach to creating spinouts
University of Notre Dame tries new, supersized approach to creating spinouts
A new $35m fund will be managed by external venture studio High Alpha Innovation and will work with the university on creating new startups.
Events
GCV Institute: Landing the Value of Corporate Venturing
May 6 -
May 9, 2024
Online
May 9, 2024
Online
Events
Webinar: CVCs and the art of the follow-on
May 8, 2024
Online
Online
Events
GCV Institute: CVC Investment Programs
May 21 -
May 22, 2024
Online
May 22, 2024
Online
Events
GCV Symposium 2024
Jun 24 -
Jun 26, 2024
London (UK)
Jun 26, 2024
London (UK)
Events
Corporate Venture in Brasil 2024 – International Delegation to Brazil
Oct 28 -
Oct 30, 2024
São Paulo (Brazil)
Oct 30, 2024
São Paulo (Brazil)
Top News
test reg